Greg Parkhurst

About Greg Parkhurst

Greg Parkhurst

After training with the first surgeon in the US to perform LASIK, Parkhurst has gone on to pioneer new trends in refractive surgery. “Nothing surpasses the privilege of restoring sight. Maintaining positions of leadership in ophthalmology is maximizing my scale-of-influence in that endeavor,” he says.

Named a Top Ophthalmologist by the Consumer’s Research Council of America, and included in the Super Doctor’s Rising Star List in Texas Monthly Magazine, he was the only surgeon under the age of 35 to serve as teaching faculty for the American-European College of Ophthalmic Surgeons. Parkhurst has also acted as principal investigator during numerous FDA clinical trials, ranging from CXL and presbyopic inlays to MIGS devices and lasers. His advice to his ophthalmology peers: “Advance the profession through publication in the peer-review literature and podium education, and endeavor for leadership as physician-CEO of your own practice.”

A nominator said: “Greg is a star. Serving for several years for the military to pay back his training, Greg is on the cutting edge of all cataract and refractive surgery technology and research. He is former Chief of Ophthalmology and Refractive Surgery at Fort Hood, and highest volume ICL surgeon in the US in 2009 and 2010. An author of multiple peer-reviewed papers and multiple textbook chapters on laser cataract surgery and phakic IOLs, Greg is also founding member of the American-European Congress of Ophthalmic Surgery and the Refractive Surgery Alliance, and current president elect.”